Annual Meeting > Trials for GYN Cancer
Make your voice heard in Washington: #Trials4GynCancerNow
During the Annual Meeting, you can take several steps to raise awareness of the crisis in gynecologic oncology clinical trials. Please join us for this important campaign and take the following actions during the Annual Meeting.
- On Monday, March 13, attendees will be asked to tweet President Trump: “Women with #gyncancer deserve progress. Fund trials now @realDonaldTrump #Trials4GynCancerNOW @sgo_org.”
- Visit the SGO Booth and take your photo with the hashtag poster. Tweet your photo with the above message and get entered to win a free registration to the 2018 Annual Meeting on Women’s Cancer in New Orleans.
- Also at the booth, go to the iPads and click on the Washington Alert icon to send a message to your elected officials in the U.S. House of Representatives and U.S. Senate.
- Can’t make it to the booth? Go to the SGO website and look for Policy/Washington Alert to send your message to federal elected leaders.
- New to social media? See the Social Media section of the SGO website for a primer, policy, procedures and popular hashtags.
A Special Member of My Team | Dee Sparacio
The first day I went for chemotherapy I really didn’t know what to expect. Two weeks earlier I had surgery and learned I had ovarian cancer. I hadn’t had time for a tour of the treatment area so I was a bit nervous.
Of Mice and Men: The Language of Medicine | Erin Stevens, MD
My third year of fellowship is my research year. Whereas I long to go back to the clinical service and talk to patients, my current patients are mice. My mice are housed on the ninth floor of the basic science building in the Department of Laboratory Animal Research, or DLAR. Over two months ago, I gave a small cohort of them ovarian cancer. I go every day to weigh them and see if they’re growing tumors. So far, it has worked in about half of them – suffice it to say I’m definitely better cut out for the clinical side of gynecologic oncology. Due to construction, the direct elevators to the DLAR have been out of service for months. You either have to take the stairs up nine flights or cut through the construction site. I usually choose the latter.
Being a Fellow in the Era of Facebook | Erin Stevens, MD
“I’m not the smartest fellow in the world, but I can sure pick smart colleagues.”
-Franklin D. Roosevelt
It all started on the interview trail. Someone started a Facebook group to keep everyone in touch though the interview process. Who was going to be at what interview, sharing hotel rooms, all the while quietly calculating where you think you fit in the grand scheme of things.
A Letter to My Patients: Promises Part 2 | Erin Stevens, MD
This is Part 2 of an excerpt of a speech I gave at the Stony Brook University Hospital’s Gynecologic Oncology Candlelight Ceremony in September 2012.
I promise to remember who my patients are. My patients are women, just like myself. And women spend most of their lives nurturing those around them, putting others first. This makes cancer a very humbling disease. Being diagnosed with cancer means reaching out to others nurturing while you are putting yourself first. It is a time when you must be at least a little selfish, which is extraordinarily difficult for most women.
A Letter to My Patients: Promises Part 1 | Erin Stevens, MD
This is Part 1 of an excerpt of a speech I gave at the Stony Brook University Hospital’s Gynecologic Oncology Candlelight Ceremony in September 2012.
Sure, I’m only a fellow. But what that means to me is that I am part of the future of the field of gynecologic oncology. I was one of the 43 people that was chosen my year to be a gyn onc fellow. I have hopes and dreams for what my career will be like. But mostly, what I have now are some promises.
June 2019, Volume 154, Supplement 1, p1-288
Abstract Supplement: Abstracts Presented for the 50th Annual Meeting of the Society of Gynecologic Oncology March 16-19, 2019, Honolulu, HI
Gynecologic Oncology August 2019: Volume 154, Issue 2
Editorial: Margins in vulvar cancer: challenges to classical clinicopathologic vulvar recurrence risk factors; Sara Dudley, Akila Viswanathan
Lead Article: Margin status revisited in vulvar squamous cell carcinoma; N.C. te Grootenhuis, A.W. Pouwer, G.H. de Bock, H. Hollema, J. Bulten, A.G.J. van der Zee, J.A. de Hullu, M.H.M. Oonk
Vulvar Cancer: Role of adjuvant radiation or re-excision for early stage vulvar squamous cell carcinoma with positive or close surgical margins; Sabrina M. Bedell, Chloe Hedberg, Anna Griffin, Hannah Pearson, Annelise Wilhite, Nathan Rubin, Britt K. Erickson
Vulvar Cancer: Evidence-based wound classification for vulvar surgery: Implications for risk adjustment; I. Mert, W.A. Cliby, K.A. Bews, E.B. Habermann, S.C. Dowdy
May 2019 Gynecologic Oncology Reports
Inpatient management of hypercalcemia portends a poor prognosis among gynecologic oncology patients: A trigger to initiate hospice care? James C. Cripe, Lindsay M. Kuroki
Evaluation of screening and risk-reducing surgery for women followed in a high-risk breast/ovarian cancer clinic: it is all about the tubes in BRCA mutation carriers Martha E. Stewart, Anne T. Knisely, Mackenzie W. Sullivan, Kari L. Ring, Susan C. Modesitt
Isolated distant lymph node metastases in ovarian cancer. Should a new substage be created? Dimitrios Nasioudis, Emily M. Ko, Ashley F. Haggerty, Robert L. GiuntoliII, Robert A. Burger, Mark A. Morgan, Nawar A. Latif
Retreatment with carboplatin and paclitaxel for recurrent endometrial cancer: A retrospective study of the Memorial Sloan Kettering Cancer Center experience Maria Rubinstein, Darragh Halpenny, Vicky Makker, Rachel N. Grisham, Carol Aghajanian, Karen Cado
Cervical cancer treatment in Haiti: A vertically-integrated model for low-resource settings Vincent DeGennaro Jr., Madelyn Shafer, Meagan Kelly, Jean Ronald Cornely, Joseph Bernard Jr.